CWM
LLY icon

Calamos Wealth Management’s Eli Lilly LLY Stock Holding History

Calamos Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8M Sell
31,292
-5,659
-15% -$5.74M 0.99% 19
2025
Q4 		$39.7M Buy
36,951
+5,491
+17% +$5.25M 1.37% 14
2025
Q3 		$24M Sell
31,460
-6,979
-18% -$5.19M 0.87% 22
2025
Q2 		$30M Buy
38,439
+7,748
+25% +$6.02M 1.27% 16
2025
Q1 		$25.3M Buy
30,691
+2,407
+9% +$2M 1.26% 15
2024
Q4 		$21.8M Buy
28,284
+319
+1% +$264K 1.09% 19
2024
Q3 		$24.8M Sell
27,965
-3,807
-12% -$3.42M 1.27% 16
2024
Q2 		$28.8M Buy
31,772
+588
+2% +$470K 1.53% 14
2024
Q1 		$24.3M Buy
31,184
+19
+0.1% +$13.5K 1.36% 14
2023
Q4 		$18.2M Sell
31,165
-238
-0.8% -$139K 1.14% 16
2023
Q3 		$16.9M Sell
31,403
-9,881
-24% -$5.09M 1.28% 16
2023
Q2 		$19.4M Sell
41,284
-577
-1% -$242K 1.42% 13
2023
Q1 		$14.4M Sell
41,861
-13,499
-24% -$4.55M 1.13% 17
2022
Q4 		$20.3M Buy
55,360
+315
+0.6% +$112K 1.57% 13
2022
Q3 		$17.8M Buy
55,045
+1,613
+3% +$511K 1.53% 13
2022
Q2 		$17.3M Buy
53,432
+879
+2% +$264K 1.54% 12
2022
Q1 		$15.1M Sell
52,553
-7,710
-13% -$1.98M 1.12% 15
2021
Q4 		$16.6M Buy
60,263
+2,768
+5% +$702K 1.22% 14
2021
Q3 		$13.3M Sell
57,495
-16,871
-23% -$4.16M 1.07% 17
2021
Q2 		$17.1M Buy
74,366
+27,013
+57% +$5.43M 1.33% 12
2021
Q1 		$8.85M Sell
47,353
-10,395
-18% -$2.03M 0.73% 32
2020
Q4 		$9.75M Buy
57,748
+2,410
+4% +$360K 0.89% 22
2020
Q3 		$8.19M Buy
55,338
+51,963
+1,540% +$8.04M 0.94% 20
2020
Q2 		$554K Buy
3,375
+1,824
+118% +$280K 0.07% 173
2020
Q1 		$215K Buy
+1,551
New +$213K 0.03% 224
2018
Q4 		– Sell
-2,039
Closed -$219K – 238
2018
Q3 		$219K Buy
+2,039
New +$204K 0.03% 196

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Calamos Wealth Management's LLY Position: Q1 2026 in Review

Calamos Wealth Management reduced its Eli Lilly (LLY) stake by 15% in Q1 2026, selling an estimated $5.74M and leaving 31,292 shares worth $28.8M. The position accounts for 0.99% of the portfolio, ranked #19.

Calamos Wealth Management first reported a position in LLY in Q3 2018 and has held it in 26 quarters since. The position peaked at $39.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Calamos Wealth Management held 31,292 shares of Eli Lilly worth $28.8M as of Q1 2026.
  • Calamos Wealth Management sold 5,659 Eli Lilly shares in Q1 2026, an estimated $5.74M.
  • Eli Lilly made up 0.99% of Calamos Wealth Management's portfolio in Q1 2026, its #19 holding.
  • Calamos Wealth Management first reported a position in Eli Lilly in Q3 2018 and has held it in 26 quarters since.
  • Calamos Wealth Management's Eli Lilly position peaked at $39.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Calamos Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.